Review: taking Lortab and Tagamet together


Summary

Drug interactions are reported among people who take Lortab and Tagamet together. This review analyzes the effectiveness and drug interactions between Lortab and Tagamet. It is created by eHealthMe based on reports of 655 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lortab and Tagamet >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lortab

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. (latest outcomes from Lortab 19,656 users)

Tagamet

Tagamet has active ingredients of cimetidine. It is often used in gastritis. (latest outcomes from Tagamet 6,054 users)

On Aug, 30, 2016

655 people who take Lortab, Tagamet are studied.


Number of reports submitted per year:

Lortab and Tagamet drug interactions.

Drug effectiveness over time:

Lortab:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Tagamet:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lortab:
  • female: 75.0% - (3 of 4 people)
  • male: 50.0% - (1 of 2 people)
Tagamet:
  • female: 40.0% - (2 of 5 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Lortab:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Tagamet:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • back pain
  • fall
  • pain in extremity
  • suicidal ideation
  • asthenia
  • contusion
  • fatigue
  • hyperhidrosis
  • joint injury
  • acute respiratory distress syndrome
1 - 6 months:
  • anaemia
  • convulsion
  • fungal sepsis
  • hypokalaemia
  • hypomagnesaemia
  • neutropenia
  • neutropenic sepsis
  • pericardial effusion
  • alopecia
  • bone pain
6 - 12 months:
  • anxiety disorder
  • arthralgia
  • arthritis
  • back pain
  • bone density decreased
  • bone disorder
  • chronic obstructive pulmonary disease
  • crohn's disease
  • depression
  • diabetes mellitus
1 - 2 years:
  • anterograde amnesia
  • dry mouth
  • dysmenorrhoea
  • gynaecomastia
  • menorrhagia
2 - 5 years:
  • short-term memory loss
  • stuttering
  • dizziness
  • facial tics
  • fatigue
  • tardive dyskinesia
  • alanine aminotransferase increased
  • ankle fracture
  • aspartate aminotransferase increased
  • back disorder
5 - 10 years:
  • ankle fracture
  • arthritis
  • asthenia
  • back disorder
  • bone disorder
  • breast mass
  • fall
  • foot fracture
  • gynaecomastia
  • headache
10+ years:
  • po2 increased
  • weight gain poor
  • anxiety
  • arthritis
  • blood glucose decreased
  • bone disorder
  • calcium deficiency
  • cataract
  • depression
  • fall
not specified:
  • pain
  • nausea
  • fatigue
  • anxiety
  • vomiting
  • dyspnoea
  • bone disorder
  • back pain
  • fall
  • anaemia

Most common drug interactions by gender *:

female:
  • pain
  • anaemia
  • nausea
  • osteomyelitis
  • swelling
  • osteoarthritis
  • osteoporosis
  • fatigue
  • back pain
  • fall
male:
  • pain
  • dyspnoea
  • nausea
  • fatigue
  • chest pain
  • anxiety
  • vomiting
  • asthenia
  • bone disorder
  • spinal osteoarthritis

Most common drug interactions by age *:

10-19:
  • pain
  • biliary dyskinesia
  • cholecystitis chronic
  • cholelithiasis
  • constipation
  • diarrhoea
  • injury
  • vomiting
  • abdominal pain lower
  • abdominal pain upper
20-29:
  • vomiting
  • back pain
  • constipation
  • nausea
  • pain
  • anxiety
  • chest pain
  • dyspnoea
  • general physical health deterioration
  • lethargy
30-39:
  • nausea
  • pancytopenia
  • colitis pseudomembranous
  • fatigue
  • neutropenia
  • dyspnoea
  • chest pain
  • headache
  • heart rate increased
  • implant infection
40-49:
  • fatigue
  • back pain
  • asthenia
  • nausea
  • pain
  • intervertebral disc protrusion
  • chest pain
  • fall
  • pyrexia
  • anxiety
50-59:
  • pain
  • anaemia
  • oedema peripheral
  • diarrhoea
  • osteoarthritis
  • bone disorder
  • swelling
  • nausea
  • pain in jaw
  • gastrooesophageal reflux disease
60+:
  • dyspnoea
  • pain
  • chest pain
  • osteonecrosis of jaw
  • constipation
  • osteoporosis
  • rectal haemorrhage
  • anxiety
  • fatigue
  • arthritis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lortab and Tagamet?


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.